Tag: retinitis pigmentosa
IDT Australia secures $3.2M manufacturing contract for investigational eye therapy
ASX-listed IDT Australia Limited has been awarded a five-year contract valued at $3.2 million for the manufacture of NPI-001 tablets, an investigational treatment for retinitis pigmentosa (RP), a degenerative eye disease that can lead to vision loss.
Featured Article
Automotive canopy and tray manufacturer manages 6,000 SKUs with self-implemented ERP
Australian automotive accessories manufacturer Trig Point self-implemented an ERP system in just three months and gained control over its unwieldy component inventory, product customizations, and production processes. “We wouldn’t be able to manage that without a system like this,” says Chris Wasylkiw, Production Engineer.
